Guardant Health Reports Q2 Non-GAAP EPS Miss and Revenue Beat
In its second-quarter financial report, Guardant Health (NASDAQ:GH) reported a non-GAAP earnings per share of -$0.42, which missed expectations by $0.03. However, the company's revenue came in at $335 million, surpassing forecasts by $20.57 million and growing 44.3% year-over-year. Looking ahead, Guardant Health updated its full-year 2026 guidance to a projected revenue range of between $1.34 billion and $1.36 billion. This reflects the company's confidence in continued growth despite missing earnings estimates this quarter.
Tickers: $GH
Topics: earnings guidance update revenue beat